246 related articles for article (PubMed ID: 26487740)
1. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
[TBL] [Abstract][Full Text] [Related]
2. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
3. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
Brennan VC; Wang CM; Yang WH
J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
[TBL] [Abstract][Full Text] [Related]
4. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
Ray RB; Raychoudhuri A; Steele R; Nerurkar P
Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
[TBL] [Abstract][Full Text] [Related]
5. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
Kilcar AY; Yildiz O; Dogan T; Sulu E; Takan G; Muftuler FZB
Anticancer Agents Med Chem; 2020; 20(12):1497-1503. PubMed ID: 32329694
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
Sur S; Nakanishi H; Flaveny C; Ippolito JE; McHowat J; Ford DA; Ray RB
Cell Commun Signal; 2019 Oct; 17(1):131. PubMed ID: 31638999
[TBL] [Abstract][Full Text] [Related]
10. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
[TBL] [Abstract][Full Text] [Related]
11. Bitter melon protects against ER stress in LS174T colonic epithelial cells.
Kunde DA; Chong WC; Nerurkar PV; Ahuja KD; Just J; Smith JA; Guven N; Eri RD
BMC Complement Altern Med; 2017 Jan; 17(1):2. PubMed ID: 28049460
[TBL] [Abstract][Full Text] [Related]
12. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
[TBL] [Abstract][Full Text] [Related]
13. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.
Shih CC; Shlau MT; Lin CH; Wu JB
Phytother Res; 2014 Mar; 28(3):363-71. PubMed ID: 23610006
[TBL] [Abstract][Full Text] [Related]
14. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
15. Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth.
Shim SH; Sur S; Steele R; Albert CJ; Huang C; Ford DA; Ray RB
Mol Carcinog; 2018 Nov; 57(11):1599-1607. PubMed ID: 30074275
[TBL] [Abstract][Full Text] [Related]
16. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
17. Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice.
Yu Y; Zhang XH; Ebersole B; Ribnicky D; Wang ZQ
Sci Rep; 2013 Nov; 3():3142. PubMed ID: 24189525
[TBL] [Abstract][Full Text] [Related]
18. Activation of AMPK by bitter melon triterpenoids involves CaMKKβ.
Iseli TJ; Turner N; Zeng XY; Cooney GJ; Kraegen EW; Yao S; Ye Y; James DE; Ye JM
PLoS One; 2013; 8(4):e62309. PubMed ID: 23638033
[TBL] [Abstract][Full Text] [Related]
19. Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.
Kaur M; Deep G; Jain AK; Raina K; Agarwal C; Wempe MF; Agarwal R
Carcinogenesis; 2013 Jul; 34(7):1585-92. PubMed ID: 23475945
[TBL] [Abstract][Full Text] [Related]
20. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
